Bristol Myers (NYSE: BMY ) Squibb and Sanofi (NASDAQ: SNY ) are also hunting for deals, according to company employees, even as some rivals have looked to exit China in the wake of COVID-related supply chain disruptions, a local economic slowdown and price cuts to get state insurance listing.